Market Overview:
The global learning disability treatment market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of learning disabilities, rising awareness about available treatments, and growing demand for better treatment options. The global learning disability treatment market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into stimulants, non-stimulants, and other medicines. Stimulants are further sub-segmented into amphetamines and methylphenidate products. Non-stimulants are further sub-segmented into atomoxetine products and guanfacine products. Other medicines are further sub-segmented into anticonvulsant drugs and antipsychotic drugs. On the basis of application, the market is segmented into hospitals, clinics,,and others (including schools/educational institutions). The hospitals segment accounted for a major share in 2017 owing to increased diagnosis rates in this sector coupled with rising demand for better treatments options.On th ebasis o fregion ,t he m arket i s segmen ted int o North America,,Latin America,,Europe,,Asia Pacific ,and Middle East & Africa . In 2017,.North America was t he largest regi onal mar ket fo r l earning disabi lity trea tment .
Product Definition:
Learning Disability Treatment is a service that helps people with learning disabilities learn and improve their skills. It can include things like therapy, medication, and special education.
Stimulants:
Stimulants are substances that increase the excitability of the nervous system. They have a positive effect on brain function and learning. Stimulants are used in various forms such as tablets, liquids, and injections for treating children with attention deficit hyperactivity disorder (ADHD) or any neurological condition associated with lack of focus, restlessness, inability to sit still or pay attention to the task at hand.
Non-Stimulants:
Non-stimulants are drugs that produce no or minimal response when they are administered to the patient. They do not produce a wakefulness effect and hence, learning disability patients may take these drugs with their meals or with water. The most commonly used non-stimulant is Atomoxetine which is also known as xeamanx when given in higher doses it produces an alerting effect which can be useful for some people but not all.
Application Insights:
The others application segment held the largest share of over 50.0% in 2017. The other medicines include antidepressants, antipsychotics, anticonvulsants and benzodiazepines among others. These medicines are generally used for the treatment of mental disorders that do not respond to other therapies such as behavior therapy or cognitive therapy. Increasing awareness about these treatments is expected to drive growth during the forecast period especially in Europe and North America regions due to high prevalence rates of learning disabilities across these regions.
Hospital based clinics are anticipated to witness lucrative growth owing to increasing awareness about available treatments coupled with rising incidences of learning disabilities across developing countries such as India.
Regional Analysis:
North America accounted for the largest share of over 40.0% in 2017, owing to the presence of a large number of global players and increased awareness about learning disabilities treatment. Moreover, high availability and adoption rate of innovative technologies are also contributing towards market growth in this region.
Asia Pacific is expected to be one of the fastest-growing regions during the forecast period due to increasing awareness among people & children suffering from LDs about their condition & available treatments as well as growing disposable income levels coupled with rising healthcare expenditure by governments across emerging economies such as India and China. These factors are expected to drive regional market growth over next eight years till 2030.
Growth Factors:
- Increasing awareness about learning disabilities and its treatment options among people.
- Growing number of research studies on learning disabilities and its treatment options, which is helping to improve the understanding about it among people.
- Increasing number of clinics and hospitals offering specialized treatments for learning disabilities.
- Rising demand for personalized treatments for different types of learning disabilities.
Scope Of The Report
Report Attributes
Report Details
Report Title
Learning Disability Treatment Market Research Report
By Type
Stimulants, Non-Stimulants, Other Medicines
By Application
Hospitals, Clinic, Others
By Companies
CogniFit, Eli Lilly & Company, Forest Laboratories, Inc., IMSE, Novartis AG, Pfizer, Inc., Shire, Plc., Therapro, Inc., Tumble N’ Dots, Inc., Texthelp Ltd.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
165
Number of Tables & Figures
116
Customization Available
Yes, the report can be customized as per your need.
Global Learning Disability Treatment Market Report Segments:
The global Learning Disability Treatment market is segmented on the basis of:
Types
Stimulants, Non-Stimulants, Other Medicines
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- CogniFit
- Eli Lilly & Company
- Forest Laboratories, Inc.
- IMSE
- Novartis AG
- Pfizer, Inc.
- Shire, Plc.
- Therapro, Inc.
- Tumble N’ Dots, Inc.
- Texthelp Ltd.
Highlights of The Learning Disability Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Stimulants
- Non-Stimulants
- Other Medicines
- By Application:
- Hospitals
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Learning Disability Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Learning disability treatment is a combination of therapies and interventions that are used to help people with learning disabilities improve their ability to learn. Treatment may include instruction in special education, tutoring, counseling, and other support services.
Some of the major players in the learning disability treatment market are CogniFit, Eli Lilly & Company, Forest Laboratories, Inc., IMSE, Novartis AG, Pfizer, Inc., Shire, Plc., Therapro, Inc., Tumble N’ Dots, Inc., Texthelp Ltd..
The learning disability treatment market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Learning Disability Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Learning Disability Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Learning Disability Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Learning Disability Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Learning Disability Treatment Market Size & Forecast, 2018-2028
4.5.1 Learning Disability Treatment Market Size and Y-o-Y Growth
4.5.2 Learning Disability Treatment Market Absolute $ Opportunity
Chapter 5 Global Learning Disability Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Learning Disability Treatment Market Size Forecast by Type
5.2.1 Stimulants
5.2.2 Non-Stimulants
5.2.3 Other Medicines
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Learning Disability Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Learning Disability Treatment Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Learning Disability Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Learning Disability Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Learning Disability Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Learning Disability Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Learning Disability Treatment Market Size Forecast by Type
9.6.1 Stimulants
9.6.2 Non-Stimulants
9.6.3 Other Medicines
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Learning Disability Treatment Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Learning Disability Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Learning Disability Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Learning Disability Treatment Market Size Forecast by Type
10.6.1 Stimulants
10.6.2 Non-Stimulants
10.6.3 Other Medicines
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Learning Disability Treatment Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Learning Disability Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Learning Disability Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Learning Disability Treatment Market Size Forecast by Type
11.6.1 Stimulants
11.6.2 Non-Stimulants
11.6.3 Other Medicines
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Learning Disability Treatment Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Learning Disability Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Learning Disability Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Learning Disability Treatment Market Size Forecast by Type
12.6.1 Stimulants
12.6.2 Non-Stimulants
12.6.3 Other Medicines
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Learning Disability Treatment Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Learning Disability Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Learning Disability Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Learning Disability Treatment Market Size Forecast by Type
13.6.1 Stimulants
13.6.2 Non-Stimulants
13.6.3 Other Medicines
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Learning Disability Treatment Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Learning Disability Treatment Market: Competitive Dashboard
14.2 Global Learning Disability Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 CogniFit
14.3.2 Eli Lilly & Company
14.3.3 Forest Laboratories, Inc.
14.3.4 IMSE
14.3.5 Novartis AG
14.3.6 Pfizer, Inc.
14.3.7 Shire, Plc.
14.3.8 Therapro, Inc.
14.3.9 Tumble N’ Dots, Inc.
14.3.10 Texthelp Ltd.
